文献速递系统性红斑狼疮其他结缔组织病

特发性血小板减少性紫癜患者系统性红斑狼疮风险:一项基于人群的队列研究

Risk of systemic lupus erythematosus in patients with idiopathic thrombocytopenic purpura: a population-based cohort study.
PubMed 文献 · Ann Rheum Dis · 2020-04-02

该回顾性队列研究分析了2000至2013年新诊断ITP患者发生SLE的风险,对照组按1:2倾向评分匹配。ITP组SLE发病率为62.0(95%CI 44.3-86.8),非ITP组为2.10(95%CI 1.44-3.06);调整后HR为25.1(95%CI 13.7-46.0),匹配后条件Cox模型HR为17.4(95%CI 5.28-57.4)。结论认为ITP患者SLE风险显著升高,临床应监测狼疮发生。

要点

  • ITP患者SLE发病率显著高于非ITP人群。
  • 调整后SLE风险增加,HR为25.1(95%CI 13.7-46.0)。
  • 临床应对ITP患者监测SLE发生。

核心结论

  • ITP患者发生SLE的风险显著高于非ITP人群。
  • 临床应对ITP患者监测偶发狼疮。

研究设计与样本

  • 基于人群的回顾性队列研究,纳入2000至2013年新诊断ITP患者。
  • 对照组按1:2比例通过倾向评分匹配(PSM)使用贪心算法选择。
  • 采用Cox比例风险模型分析ITP与SLE发病的关联,并实施敏感性分析。

主要发现

  • 年龄和性别匹配的ITP与非ITP队列平均随访约80个月。
  • ITP组SLE发病34例(4.70%),非ITP组27例(0.19%)。
  • ITP组SLE发病率为62.0(95%CI 44.3-86.8),非ITP组为2.10(95%CI 1.44-3.06)。
  • ITP组调整后SLE的HR为25.1(95%CI 13.7-46.0)。
  • PSM后条件Cox模型估计HR为17.4(95%CI 5.28-57.4)。

关键数值与推荐

  • ITP组SLE发病34例(4.70%),非ITP组27例(0.19%)。
  • ITP组SLE发病率62.0(95%CI 44.3-86.8),非ITP组2.10(95%CI 1.44-3.06)。
  • 调整后HR 25.1(95%CI 13.7-46.0),PSM后条件Cox模型HR 17.4(95%CI 5.28-57.4)。
  • SLE的其他风险因素包括女性性别和干燥综合征。

临床怎么用

  • 对ITP患者应监测SLE的发生。
  • 女性ITP患者及合并干燥综合征者可能需更关注SLE风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Idiopathic thrombocytopenic purpura (ITP) may play a role in early-stage systemic lupus erythematosus (SLE). The incidence of SLE in patients with ITP and the potential relationship between them is still unclear. This study was performed to provide epidemiological evidence regarding the relationship between ITP and SLE occurrence. METHODS: In this population-based retrospective cohort study, the risk of SLE was analysed in a cohort of patients newly diagnosed with ITP between 2000 and 2013. Controls were selected at a 1:2 ratio through propensity score matching (PSM) using the greedy algorithm. The Cox proportional hazard model was used to analyse the association between ITP and SLE incidence. There were four different Cox regression models, and the sensitivity analyses were implemented to evaluate the HR of SLE after exposure with ITP. RESULTS: In the age-matched and sex-matched ITP and non-ITP cohort, the average follow-up time was about 80 months in this study. There were 34 (4.70%) and 27 (0.19%) incident cases of SLE in ITP and non-ITP group. The incidence rates were 62.0 (95% CI 44.3 to 86.8) and 2.10 (95% CI 1.44 to 3.06), respectively. The adjusted HR of incidental SLE in the ITP group was 25.1 (95% CI 13.7 to 46.0). The other risk factors for SLE were female sex and Sjogren's syndrome. After PSM, the incidence rate and Kaplan-Meir curves of SLE were consistent with the results for the age-matched and sex-matched population, the HR 17.4 (95% CI 5.28 to 57.4) was estimated by conditional Cox model. CONCLUSION: This cohort study demonstrated that patients with ITP have a higher risk of SLE. Clinically, patients with ITP should be monitored for incidental lupus.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Zhu FX, Huang JY, Ye Z, et al. Risk of systemic lupus erythematosus in patients with idiopathic thrombocytopenic purpura: a population-based cohort study. Ann Rheum Dis. 2020. PMID: 32241798. doi:10.1136/annrheumdis-2020-217013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。